Healthcare technology company Bright Health Group (NYSE:BHG) said it expects FY23 revenue to be between $3.4B and $3.6B, vs. a consensus of $3.83B.
Also, the company reinforced its 2023 adjusted EBITDA profitability expectation, and said value-based consumers will be in the range of 275,000 – 300,000.
BHG expects FY23 adjusted operating cost ratio in the range of 11% to 12% and more than 125,000 senior managed care end of year consumers.
CEO Mike Mikan is set to provide additional commentary on the company's outlook at the 41st Annual J.P. Morgan Healthcare Conference on Jan. 11.